Announcements
- IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
- IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
- IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
- IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
- IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
- IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue
- IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
- IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per share
- IRADIMED CORPORATION Named a 2024 Most Successful Small-Cap Company in America by Forbes
- IRADIMED CORPORATION Announces Third Quarter 2023 Financial Results
More ▼
Key statistics
As of last trade, IRadimed Corp (46K:STU) traded at 38.80, 12.14% above the 52 week low of 34.60 set on Oct 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 38.00 |
---|---|
High | 38.80 |
Low | 38.00 |
Bid | 38.40 |
Offer | 40.00 |
Previous close | 38.20 |
Average volume | 0.00 |
---|---|
Shares outstanding | 12.66m |
Free float | 7.97m |
P/E (TTM) | 30.31 |
Market cap | 540.13m USD |
EPS (TTM) | 1.41 USD |
Annual div (ADY) | 0.5521 EUR |
---|---|
Annual div yield (ADY) | 1.42% |
Div ex-date | May 17 2024 |
Div pay-date | May 30 2024 |
Data delayed at least 15 minutes, as of May 16 2024.
More ▼